People with generalized myasthenia gravis (gMG) treated with the experimental therapy rozanolixizumab in a clinical trial generally experienced…
Marisa Wexler, MS
senior science writer
Marisa Horak joined Bionews in 2018 right after she completed her master’s degree in cellular and molecular pathology. She has dedicated her career to making scientific and medical information more accessible to people affected by rare and chronic disorders.
Education
- MS, Cellular and Molecular Pathology, University of Pittsburgh
- BS, Microbiology, Michigan State University
Professional Accomplishments
- Universal concept signature analysis: genome-wide quantification of new biological and pathological functions of genes and pathways, 2019, Briefings in Bioinformatics
- Epigenetic activation of HORMAD1 in basal-like breast cancer: role in Rucaparib sensitivity, 2018, Oncotarget
- Insights on processes of evolutionary tumor growth, 2016, Atlas Genet Cytogenet Oncol Haematol
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
Treatment with Vyvgart (efgartigimod alfa-fcab) over two years was found to safely and effectively ease symptoms of…
Treatment with the experimental therapy zilucoplan eased symptoms of generalized myasthenia gravis (gMG) across different subgroups of patients…
Robot-assisted surgery to remove the thymus is generally safe for people with myasthenia gravis (MG), with most patients who…
For people with rare health conditions like myasthenia gravis (MG), navigating the U.S. health insurance system can be difficult,…
Life with myasthenia gravis (MG) often means finding new ways to do things that used to be easy but…
For people with myasthenia gravis (MG) and other chronic diseases, it’s important to be proactive in learning how to…
Maintaining a hopeful outlook is a vital part of managing myasthenia gravis (MG). Hope can help improve a person’…
Vyvgart (efgartigimod) won approval in the U.K. as an add-on to standard therapy for adults with generalized myasthenia…
Early and aggressive treatments tend to lead to better control of myasthenia gravis (MG) symptoms, a recent study reports.